Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €7.24 EUR
Change Today +0.141 / 1.99%
Volume 3.7K
APS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 1:50 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Timothy P. Clackson Ph.D.

Chief Scientific Officer and President of Research & Development, Ariad Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

50$1,688,050
As of Fiscal Year 2014

Background*

Dr. Timothy P. Clackson, also known as Tim, Ph.D. has been Chief Scientific Officer of ARIAD Pharmaceuticals Inc. on September 30, 2003 and has been its President of Research and Development since June 2010. Dr. Clackson served as Senior Vice President, Science and Technology of Ariad Pharmaceuticals Inc. from June 2002. Previously, Dr. Clackson served as Vice President, Gene Therapy and Genomics of ARIAD Pharmaceuticals, Inc. from June 2000 to June 2002, as Director, ...

Read Full Background

Corporate Headquarters*

26 Landsdowne Street
Cambridge, Massachusetts 02139

United States

Phone: 617-494-0400
Fax: 617-494-8144

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
University of Cambridge
BA
University of Oxford

Other Affiliations*

Annual Compensation*

Salary$493,000
Bonus$365,000
Total Annual Compensation$858,000

Stock Options*

Restricted Stock Awards$650,320
All Other Compensation$32,075
Exercisable Options291,817
Exercisable Options Value$346,836
Unexercisable Options70,666
Total Value of Options$346,835
Total Number of Options362,483

Total Compensation*

Total Annual Cash Compensation$890,075
Total Short Term Compensation$858,000
Other Long Term Compensation$682,395
Total Calculated Compensation$1,688,050
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
APS:GR €7.24 EUR +0.141

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer, President and Principal Financial Officer
Arena Pharmaceuticals, Inc.
$746.8K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma Inc.
$548.8K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$755.2K
Werner Lanthaler MBA,MPAChief Executive Officer and Member of Management Board
Evotec AG
€459.0K
Aijaz Tobaccowalla Managing Director, Director, Member of Board Administrative & Share Transfer Committee, Member of Nomination & Remuneration Committee, Member of Corporate Social Responsibility Committee and Member of Audit Committee
Pfizer Limited
52.4M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARIAD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.